Polymerase chain reaction (PCR) is widely used for the DNA amplification technique. It generates duplicates of thousands to millions in a particular DNA sequence. The PCR industry is changing its approach to large-scale systems and also focusing on the developing of micro-scale devices. Micro scale devices offer several advantages, such as it requires less reaction time, size of microscopic specimens requires less blood from patients, and offering economic benefits, since many microfluidic devices are made from inexpensive polymers.
The growth for Asia-Pacific Polymerase Chain Reaction market is driven due to factors like rising prevalence of infectious diseases, increasing geriatric population, rising number of diagnostic centers and hospitals, growing awareness about personalized medicines. In addition, technological advancements, accurate and timely results for RT-PCR, increasing investments for R&D activities by private organizations are expected to drive the market growth. However, presence of alternative technology such as next-generation sequencing, and high cost of PCR technologies are expected to decline the growth rate for Asia-Pacific Polymerase Chain Reaction Market during the forecast period.
Based on geography the Asia-Pacific Polymerase Chain Reaction Market has been primarily divided into China, India, South Korea, Japan and Australia. India and China are rapidly growing due to growing incidence of chronic diseases, increasing geriatric population, and rising technological advancement in medical sector which is expected to witness high growth rate for the Polymerase Chain Reaction market during the forecast period.
Leading companies for Asia-Pacific Polymerase Chain Reaction market are Beckman Coulter, Becton, Dickinson and Company, Cepheid, Clontech Laboratories, Eppendorf, Fluidigm, PerkinElmer, bioMérieux, GE, Harvard Bioscience, Maxim Biotech, Promega, Kapa Biosystems, RainDance Technologies, and Siemens Healthcare.
Market Data Forecast is a market research firm offering syndicated research, consults and industry newsletters across various domains & verticals. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for the majority of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest. Our experience and in-depth understanding of various business environments will be a support to you and your organization in making well-informed decisions.